FARYDAK is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Panobinostat Lactate.
| Product ID | 0078-0651_7ff8957b-38c4-4554-af66-119cd85a218e |
| NDC | 0078-0651 |
| Product Type | Human Prescription Drug |
| Proprietary Name | FARYDAK |
| Generic Name | Panobinostat |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-02-23 |
| Marketing Category | NDA / NDA |
| Application Number | NDA205353 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | PANOBINOSTAT LACTATE |
| Active Ingredient Strength | 15 mg/1 |
| Pharm Classes | Histone Deacetylase Inhibitor [EPC],Histone Deacetylase Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2015-02-23 |
| Marketing End Date | 2022-12-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA205353 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-02-23 |
| Marketing End Date | 2022-12-31 |
| Ingredient | Strength |
|---|---|
| PANOBINOSTAT LACTATE | 15 mg/1 |
| SPL SET ID: | 7774972a-eeaa-4b9a-9e56-3fc1b968e86a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0650 | FARYDAK | panobinostat |
| 0078-0651 | FARYDAK | panobinostat |
| 0078-0652 | FARYDAK | panobinostat |
| 73116-100 | FARYDAK | panobinostat |
| 73116-101 | FARYDAK | panobinostat |
| 73116-102 | FARYDAK | panobinostat |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FARYDAK 86140638 4765286 Live/Registered |
SECURA BIO, INC. 2013-12-11 |
![]() FARYDAK 79050673 3502071 Live/Registered |
Secura Bio, Inc. 2008-02-01 |